The Pathogenesis of Liver Diseases in Pregnancy

Christopher Chang

DOI: https://doi.org/10.1007/978-3-030-51709-0_33

2020-01-01

Abstract:Liver diseases that occur in pregnancy include acute fatty liver of pregnancy (AFLP); hemolysis, elevated liver enzymes, and low platelet (HELLP) syndrome; hyperemesis gravidarum; intrahepatic cholestasis of pregnancy; and preeclampsia/eclampsia. Both AFLP and HELLP syndrome can be associated with high morbidity and even mortality in the mother and the fetus. The pathogenesis of AFLP is unclear but may involve defects in fetoplacental fatty acid metabolism. Twenty percent of AFLP has been traced to a deficiency in long-chain 3-hydroxyl acyl CoA dehydrogenase. Similarly, the pathogenesis of HELLP is variable and in some cases not entirely clear, but it has been suggested that it can be viewed as a more severe form of preeclampsia. Severe eclampsia can also present with liver dysfunction. The pathogenesis of some forms of HELLP may involve a microangiopathic thrombosis. Hyperemesis gravidarum presents early in pregnancy, while AFLP and HELLP are seen in the later stages of pregnancy. In addition to these conditions, patients with existing liver diseases such as autoimmune hepatitis may become pregnant and are generally categorically characterized as high-risk pregnancies. When evaluating a patient for liver diseases during pregnancy, one must consider the normal physiologic changes that occur during pregnancy, which may predispose women to liver diseases.